Haemopoietic stem cell inhibition: potential for dose intensification.

2.50
Hdl Handle:
http://hdl.handle.net/10541/98821
Title:
Haemopoietic stem cell inhibition: potential for dose intensification.
Authors:
Marshall, E
Affiliation:
CRC Department of Medical Oncology, Christie CRC Research Centre, Christie Hospital NHS Trust, Manchester, UK.
Citation:
Haemopoietic stem cell inhibition: potential for dose intensification. 1995, 31A (10):1586-91 Eur. J. Cancer
Journal:
European Journal of Cancer
Issue Date:
Sep-1995
URI:
http://hdl.handle.net/10541/98821
DOI:
10.1016/0959-8049(95)00302-Y
PubMed ID:
7488406
Type:
Article
Language:
en
ISSN:
0959-8049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorMarshall, Een
dc.date.accessioned2010-05-14T11:05:10Z-
dc.date.available2010-05-14T11:05:10Z-
dc.date.issued1995-09-
dc.identifier.citationHaemopoietic stem cell inhibition: potential for dose intensification. 1995, 31A (10):1586-91 Eur. J. Canceren
dc.identifier.issn0959-8049-
dc.identifier.pmid7488406-
dc.identifier.doi10.1016/0959-8049(95)00302-Y-
dc.identifier.urihttp://hdl.handle.net/10541/98821-
dc.language.isoenen
dc.subjectCanceren
dc.subjectHaematopoietic Stem Cellsen
dc.subject.meshAntineoplastic Agents-
dc.subject.meshCell Cycle-
dc.subject.meshChemokine CCL4-
dc.subject.meshCytokines-
dc.subject.meshDose-Response Relationship, Drug-
dc.subject.meshGrowth Inhibitors-
dc.subject.meshHematopoietic Stem Cells-
dc.subject.meshHumans-
dc.subject.meshMacrophage Inflammatory Proteins-
dc.subject.meshMonokines-
dc.subject.meshNeoplasms-
dc.subject.meshOligopeptides-
dc.subject.meshPyrrolidonecarboxylic Acid-
dc.titleHaemopoietic stem cell inhibition: potential for dose intensification.en
dc.typeArticleen
dc.contributor.departmentCRC Department of Medical Oncology, Christie CRC Research Centre, Christie Hospital NHS Trust, Manchester, UK.en
dc.identifier.journalEuropean Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.